Applications of L-Glutamic Acid 5-Tert-Butyl 1-Methyl Ester Hydrochloride in Industrial Manufacturing

L-Glutamic Acid 5-Tert-Butyl 1-Methyl Ester Hydrochloride is a specialty intermediate widely used by pharmaceutical, peptide, and fine chemical manufacturers. Its unique structure and reactivity enable precise introduction into high-value synthetic routes. Below, we detail typical industrial applications where our material plays a vital role, with focus on specific compliance guidelines, incorporation ratios, downstream integration points, and end-use products.

1. Active Pharmaceutical Ingredient (API) Synthesis for Peptide Drugs

API manufacturers incorporate this ester hydrochloride in the solid-phase and solution-phase synthesis of protected glutamic acid residues. It ensures clean coupling, minimizes racemization, and enhances yield of target peptide chains in both research and commercial API lines. Our production meets the rigorous requirements for regulated markets, supporting both investigational and approved drug molecule manufacturing.

Industry compliance standards

• Current Good Manufacturing Practices (cGMP, ICH Q7)
• United States Pharmacopeia (USP) General Chapter <1045> on peptides
• European Pharmacopoeia (Ph. Eur.) for amino acid derivatives
• ICH Q11 guidelines on starting materials

Typical usage ratio

• Used at 1.0–1.2 molar equivalents per glutamic acid site within peptide chains
• Actual ratio adjusted based on peptide length, sequence complexity, and protection requirements

Downstream process integration

• Introduced at the amino acid coupling stage in SPPS or LPPS platforms
• Optimal for Fmoc/Boc-protected peptide synthesis pathways
• Chemical incorporation prior to global deprotection and peptide cleavage

Final product types

• Therapeutic peptides
• Peptide-based drug candidates in clinical pipelines
• Peptide reference standards
• Peptide fragment intermediates for further elaboration

2. Custom Oligopeptide Synthesis for Diagnostic Reagents

Diagnostic reagent firms frequently require protected amino acid esters for assembling oligopeptides used in immunoassays, biosensor calibrators, or molecular probes. Our material delivers consistent coupling efficiency and purity profiles that support reproducibility in detection kits and quality control reagents, crucial for the diagnostic industry's stringent standards.

Industry compliance standards

• ISO 13485:2016 for in vitro diagnostic manufacturing
• FDA 21 CFR Part 820 (QSR) for medical device production
• IVD directive (EU 2017/746) for reagent safety
• Internal quality spec sheets for trace level control

Typical usage ratio

• Applied at 1.05–1.25 equiv. per glutamic acid insertion, adjusted per probe design
• Variations based on oligopeptide length and complexity; process QC governs overages

Downstream process integration

• Dosed during stepwise chain assembly on automated peptide synthesizers
• Used for selective side-chain protection and ester release prior to labeling
• Cleaved after target sequence completion, before downstream conjugation steps

Final product types

• Calibrator peptides for immunoassay test kits
• Synthetic oligopeptides for ELISA or lateral flow devices
• Bioactive labeling reagents
• Quality control benchmarks for diagnostics

3. Research-Grade Amino Acid Derivative for Chemical Biology Tools

Chemical biology laboratories and specialty research chemical suppliers use this glutamic acid ester salt to introduce controlled protection patterns in building block libraries and probe molecules. Integration of the tert-butyl, methyl ester, and hydrochloride groups permits sequential deprotection for structure-activity investigations and profiling of enzyme substrate specificity.

Industry compliance standards

• Analytical standards conforming to ACS Reagent Grade
• Internal lab QC protocols for NMR and LC–MS purity
• ISO/IEC 17025 for accredited test laboratories
• Responsible Care® program for safe material handling

Typical usage ratio

• Commonly applied at 0.95–1.1 molar equivalent for model substrate synthesis
• Adjustable by experimental needs and screening project scope

Downstream process integration

• Added early in multistep solid-phase or solution-phase syntheses
• Semipreparative HPLC or crystallization purification follows use
• Compatible with common deprotection and coupling methodologies

Final product types

• Enzyme substrates for specificity mapping
• Fluorescently labeled glutamic acid derivatives
• Affinity probes and immobilized ligands
• Bioorthogonal building blocks for chemical biology

4. Specialty Intermediate for Agrochemical Lead Optimization

Agrochemical R&D units employ this compound as a protected glutamic acid intermediate during synthesis of amino acid-based herbicide analogs and plant growth regulator prototypes. The ester and tert-butyl groups allow controlled functional group exposure through later deprotection steps, facilitating optimization of target molecule activity and stability for field trial candidates.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• ISO 9001:2015 for development and manufacturing quality management
• REACH regulation—Annex IV; amino acid derivatives pre-registration
• Company-specific impurity thresholds for field test safety

Typical usage ratio

• Dosed at 1.0–1.15 molar equiv. as a core intermediate in multistep synthesis
• Optimized based on route efficiency and protection requirements of analog library

Downstream process integration

• Used as a key building block in ligand synthesis routes to candidate compounds
• Integrated before global deprotection and functional group elaboration
• Final product purification typically follows hydrogenolysis or acid cleavage

Final product types

• Experimental herbicide lead molecules
• Novel plant growth regulator candidates
• Reference standards for residue studies
• Agrochemical structure–activity relationship (SAR) intermediates